Efficacy Assessment of Lenvatinib Associated with Pembrolizumab in Metastatic Endometrial Cancer: a French Multicentric Retrospective Early Access Program-based Study

Clinical trial NCT06599463 · COMPLETED

Trial details

NCT number: NCT06599463
Sponsor: ARCAGY/ GINECO GROUP
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Endometrial Cancer

Start date: 2024-08-19
Primary completion: 2025-02-28
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.